Mark N Rogers plans 5,000-share Amkor sale (NASDAQ: AMKR)

Rhea-AI Filing Summary

Mark N Rogers has filed a notice to sell 5,000 shares of Amkor Technology common stock. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $234,600 and 247,193,437 shares outstanding.

The 5,000 shares were acquired on the same date via a stock option exercise paid in cash. Over the past three months, Rogers previously sold 5,000 shares for $246,400 and 20,000 shares for $859,094, all in Amkor common stock.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	234600.00	247193437	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Stock Option Exercise	ISSUER			5000	02/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARK N ROGERS 2045 East Innovation Circle Tempe AZ 85284	Common	01/16/2026	5000	246400.00
MARK N ROGERS 2045 East Innovation Circle Tempe AZ 85284	Common	12/16/2025	20000	859094.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider transaction did AMKR’s Mark N Rogers report on Form 144?

Mark N Rogers filed to sell 5,000 Amkor Technology common shares. The planned NASDAQ sale, through Morgan Stanley Smith Barney LLC, has an aggregate market value of $234,600 based on the figures listed in the notice.

How did Mark N Rogers acquire the 5,000 AMKR shares he plans to sell?

The 5,000 Amkor shares were acquired via a stock option exercise on the same date as listed for the planned sale. The filing states the exercise was paid in cash, indicating a standard option exercise followed by a proposed sale.

What recent AMKR stock sales has Mark N Rogers already completed?

During the past three months, Mark N Rogers sold 5,000 Amkor common shares for $246,400 and 20,000 shares for $859,094. These earlier transactions are disclosed alongside the new proposed 5,000-share sale in the same notice.

Which broker is handling Mark N Rogers’ planned AMKR share sale?

The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s address is given as 1 New York Plaza, 8th Floor, New York, NY 10004, with the transaction listed for trading on the NASDAQ exchange.

How many AMKR shares were outstanding in Mark N Rogers’ Form 144 filing?

The notice states that 247,193,437 Amkor common shares were outstanding. This figure provides context for the scale of Rogers’ planned 5,000-share sale relative to the company’s total common stock base at the time of the filing.

Does the AMKR Form 144 filing include any Rule 10b5-1 trading plan details?

The form includes a field for the date of plan adoption or trading instruction under Rule 10b5-1 but does not provide a specific date. It also reiterates the standard representation about not possessing undisclosed material adverse information when signing.